A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas' disease
- PMID: 38368155
- DOI: 10.1016/j.pt.2024.02.002
A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas' disease
Abstract
The drug discovery pipeline for leishmaniasis and trypanosomiasis has been filling with novel chemical entities with known mechanisms of action. González et al. and Braillard et al. report a cytochrome bc1 complex inhibitor as another promising preclinical candidate for visceral leishmaniasis (VL) and, in combination with benznidazole, for chronic Chagas' disease (CCD).
Keywords: chronic Chagas’ disease; cytochrome b; drug combinations; visceral leishmaniasis.
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical